IMI AMR Accelerator

Webinar: Animal infection models to study antibiotics against gram-negative bacteria (AMR Accelerator Members Only)
2020-11-18 15:00 - 16:00 (Europe/Berlin) | Online, RI
This webinar provided an overview of animal infection models commonly used for studies of antibiotics against gram-negative bacteria. The webinar was driven by the COMBINE objective to harmonse and standardise a protocol for a mouse infection model used for efficacy and PKPD studies. The infection model was validated through well-characterised bacterial strains and control compounds in different animal labs. During the webinar we initiated a discussion on pro’s and con’s of various procedures and animal models, aiming to guide which animal infection model COMBINE should focus on.
For additional information about the webinar, please contact Jennifer Hoover (Jennifer.L.Hoover@gsk.com) or Lena Friberg (lena.friberg@farmaci.uu.se).
Speakers:
Sylvie Sordello, COMBINE WP5 and Evotec
Jon Hansen, COMBINE WP5 and Statens Serum Institut
Jennifer Hoover, COMBINE WP5 and GlaxoSmithKline

AMR Conference
2020-08-24 - 2020-08-28 | Online
Join online over 400 international AMR experts for a week-long learning and networking experience.
The 4th AMR conference is the one-stop-shop for all AMR stakeholders from industry, SMEs, start-ups, big pharma, academia, clinics, regulatory bodies, investors, public institutions and policy to discuss all relevant challenges of bringing new antimicrobial treatments and diagnostics in the market.

What’s different this year?

In view of the continuing uncertain situation and travel restrictions due to the COVID-19 pandemic, we have decided to implement the 4th AMR Conference as a digital format in the week of 24–28 August 2020.
The current global health crisis caused by COVID-19 shows more than ever the importance of infectious diseases expertise and the high need for further fighting against antimicrobial resistance (AMR). A cross-sectoral international dialogue with all stakeholders involved will be crucial to help implement innovative therapies and diagnostics in the clinical practice globally.
Together with our supporters – among others our major partner, the BEAM Alliance – the AMR Conference will continue to provide a (virtual) platform for those debates bringing together stakeholders from industry, SMEs, start-ups, academia, clinics, investors, public institutions and policy. Within our digital AMR Conference Week in August, we want to catch up discussing the challenges of bringing new antimicrobial treatments and diagnostics into the market and as a result, help to establish a post-COVID policy roadmap on AMR.
Five days of insights and networking for the global AMR community: Each conference day will cover a focus topic with selected LIVE sessions and high-level panels. Additionally, you will be able to explore scientific poster presentations and participate in virtual 1:1 meetings throughout the whole week and to engage within our new digital AMR stakeholder platform which is currently being set up.

Webinar: AMR Accelerator data management, setting up data workflows from electronic lab notebooks to performing cross-study analyses (AMR Accelerator Members Only)
2020-07-02 16:00 - 17:00

IMI AMR Accelerator Cross-Pillar Meeting (AMR Accelerator Members Only)
2020-06-30 13:00 | Online, RI
Virtual closed meeting for IMI AMR Accelerator partners to get up to speed with the most novel developments from the Consortium’s projects.

About this Event

IMI AMR Cross-Pillar Meeting (invitation only)
This was an online meeting where partners were introduced to the AMR Accelerator projects and heard from Dr Timothy Rawson, Honorary Clinical Research Fellow, Imperial College London, who gave a keynote on COVID-19 and the recent studies he led on co-infection. Project partners could then network in break-out sessions.
For questions, please contact Clément Robijns: c.robijns@biocom.de

/// AGENDA ///

13:00 – 13:10
Welcome and introduction by COMBINE

Project presentations followed by Q&A

13:10 – 14:40
Respiri-TB &-NTM, GNA NOW, AB-Direct, ERA4TB, COMBINE
Short pitches & updates from the projects

Coffee break

14:50 – 15:40
Keynote on COVID-19 and AMR: Timothy Rawson, Imperial College London – followed by Q&A

15:40 – 16:00
(-16:30)
Breakout sessions – virtual roundtables

Webinar: FAIR knowledge and data resources in the IMI AMR Accelerator (AMR Accelerator Members Only)
2020-04-15 16:00 - 17:00
This webinar described the benefits of using FAIR approaches in data handling, where results from your studies are made Findable, Accessible, Interoperable and Reusable. The “ins and outs” of working with data were described and how teams can establish a streamlined analysis workflow in the projects. The group also demonstrated the GRIT42 software tool which was used in the AMR Accelerator to aggregate, store and analyse important data sets including reference data on antibiotic and anti-TB compounds from in-vitro and in-vivo studies.

For additional information, please contact Gesa Witt (gesa.witt@itmp.fraunhofer.de) or Philip Gribbon (philip.gribbon@itmp.fraunhofer.de).
